📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Targeting the GBA1 pathway to slow Parkinson disease: Insights into clinical aspects, pathogenic mechanisms and new therapeutic avenues. (2023)

First Author: Menozzi E

Attributed to: JPND GBA - personalised medicine for Parkinson disease: clinical and therapeutic stratification funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.pharmthera.2023.108419

PubMed Identifier: 37080432

Publication URI: http://europepmc.org/abstract/MED/37080432

Type: Journal Article/Review

Volume: 246

Parent Publication: Pharmacology & therapeutics

ISSN: 0163-7258